C12N 2710/16163
By chemical treatment
Official title: by chemical treatment
C12N2710/16163 (By chemical treatment) appears on 7 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 3
- Assignees
- 5
- Inventors
- 25
- Latest grant
- 19 Apr 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Cytomegalovirus inhibitor compounds19 Apr 2016US 9,315,499 B2Boehringer Ingelheim International GmbH
- Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer26 Jun 2001US 6,251,644 B1Baxter International Inc.
- Method of inactivation of viral and bacterial blood contaminants2 Jan 2001US 6,169,109 ABaxter International Inc.
- Method of inactivation of viral and bacterial blood contaminants9 Feb 1999US 5,869,701 ABaxter International Inc.
- Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer25 Aug 1998US 5,798,238 ABaxter International Inc.
- Replication-defective vaccines and uses thereof7 Dec 2023US 2023/0390386 A1Rutgers, The State University of New Jersey
- Compositions and methods for inhibiting viral activity4 Feb 2016US 2016/0030518 A1The Regents of the University of California
- Cytomegalovirus inhibitor compounds11 Jun 2015US 2015/0158861 A1Boehringer Ingelheim International GmbH
Most cited
By later US patents
- Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer42US 5,798,238 ABaxter International Inc. · 1998
- Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins33US 5,516,629 ACryopharm Corporation · 1996
- Method of inactivation of viral and bacterial blood contaminants26US 5,869,701 ABaxter International Inc. · 1999
- Method of inactivation of viral and bacterial blood contaminants13US 5,789,601 ABaxter International Inc. · 1998
- Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer4US 6,251,644 B1Baxter International Inc. · 2001